| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 138, 149-163, Copyright © 1991 by American Society for Investigative Pathology
REGULAR ARTICLES |
SJ Hamilton-Dutoit, G Pallesen, MB Franzmann, J Karkov, F Black, P Skinhoj and C Pedersen
Laboratory of Immunohistology, University Institute of Pathology, Aarhus Kommunehospital, Denmark.
To investigate the range of pathology shown by acquired immune deficiency syndrome (AIDS)-related lymphomas arising in an epidemiologically well-defined group of patients, all cases of lymphoma recognized in Danish human immunodeficiency virus (HIV)-infected individuals up to the end of 1988 were studied. Twenty-seven cases (26 high-grade non-Hodgkin's lymphoma [NHL], 1 Hodgkin's disease) were found, to give a cumulative incidence rate of 8% among Danish AIDS patients. Morphologically most NHL patients were classified into two groups: 1) high-grade tumors with a predominant population of immunoblasts, either monomorphic or more often polymorphic with plasmacytic differentiation; 2) Burkitt-type. Of 26 NHLs, 22 had a B- cell paraffin-section immunophenotype and 4 were non-B, non-T. Epstein- Barr virus (EBV) DNA was demonstrated in tumor cells of 12 of 24 cases (50%) using in situ nucleic acid hybridization with a 35S-labeled probe in paraffin sections. Epstein-Barr virus DNA was found in 65% of group 1 and 20% of group 2 tumors. This study suggests the existence of two main groups of AIDS-related lymphoma with different pathogeneses. First there are immunoblast-rich lesions, which usually are associated with EBV and morphologically resemble lymphomas described in immunosuppressed organ-transplantation patients. Second there are Burkitt-type tumors in which EBV sequences are less common and that may be pathogenetically analogous to sporadic Burkitt's lymphoma.
This article has been cited by other articles:
![]() |
M.-S. Zeng, D.-J. Li, Q.-L. Liu, L.-B. Song, M.-Z. Li, R.-H. Zhang, X.-J. Yu, H.-M. Wang, I. Ernberg, and Y.-X. Zeng Genomic Sequence Analysis of Epstein-Barr Virus Strain GD1 from a Nasopharyngeal Carcinoma Patient J. Virol., December 15, 2005; 79(24): 15323 - 15330. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Y. Yang, L.-W. Koh, J.-H. Tsai, C.-H. Tsai, E. F.-C. Wong, S.-J. Lin, and C.-C. Yang Involvement of Viral and Chemical Factors with Oral Cancer in Taiwan Jpn. J. Clin. Oncol., April 1, 2004; 34(4): 176 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Aljurf, T. W. Owaidah, A. Ezzat, E. Ibrahim, and A. Tbakhi Antigen- and/or immune-driven lymphoproliferative disorders Ann. Onc., November 1, 2003; 14(11): 1595 - 1606. [Full Text] [PDF] |
||||
![]() |
K. C.M. Straathof, C. M. Bollard, C. M. Rooney, and H. E. Heslop Immunotherapy for Epstein-Barr Virus-Associated Cancers in Children Oncologist, February 1, 2003; 8(1): 83 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Fournel-Fleury, F. Ponce, P. Felman, A. Blavier, C. Bonnefont, L. Chabanne, T. Marchal, J. L. Cadore, I. Goy-Thollot, D. Ledieu, et al. Canine T-cell Lymphomas: A Morphological, Immunological, and Clinical Study of 46 New Cases Vet. Pathol., January 1, 2002; 39(1): 92 - 109. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Hecht and J. C. Aster Molecular Biology of Burkitt's Lymphoma J. Clin. Oncol., November 1, 2000; 18(21): 3707 - 3721. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. I. Cohen Epstein-Barr Virus Infection N. Engl. J. Med., August 17, 2000; 343(7): 481 - 492. [Full Text] [PDF] |
||||
![]() |
M. Teitell, M. A. Damore, G. G. Sulur, D. E. Turner, M.-H. Stern, J. W. Said, C. T. Denny, and R. Wall TCL1 oncogene expression in AIDS-related lymphomas and lymphoid tissues PNAS, August 17, 1999; 96(17): 9809 - 9814. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Moses, J. Nelson, and G. C. Bagby Jr The Influence of Human Immunodeficiency Virus-1 on Hematopoiesis Blood, March 1, 1998; 91(5): 1479 - 1495. [Full Text] [PDF] |
||||
![]() |
Q. Tao, K. D. Robertson, A. Manns, A. Hildesheim, and R. F. Ambinder Epstein-Barr Virus (EBV) in Endemic Burkitt's Lymphoma: Molecular Analysis of Primary Tumor Tissue Blood, February 15, 1998; 91(4): 1373 - 1381. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Carbone, G. Gaidano, A. Gloghini, L. M. Larocca, D. Capello, V. Canzonieri, A. Antinori, U. Tirelli, B. Falini, and R. Dalla-Favera Differential Expression of BCL-6, CD138/Syndecan-1, and Epstein-Barr Virus-Encoded Latent Membrane Protein-1 Identifies Distinct Histogenetic Subsets of Acquired Immunodeficiency Syndrome-Related Non-Hodgkin's Lymphomas Blood, February 1, 1998; 91(3): 747 - 755. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Beatty, J. J. Callanan, A. Terry, O. Jarrett, and J. C. Neil Molecular and Immunophenotypical Characterization of a Feline Immunodeficiency Virus (FIV)-Associated Lymphoma: a Direct Role for FIV in B-Lymphocyte Transformation? J. Virol., January 1, 1998; 72(1): 767 - 771. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dolcetti, P. Zancai, V. De Re, A. Gloghini, B. Bigoni, B. Pivetta, S. De Vita, A. Carbone, and M. Boiocchi Epstein-Barr Virus Strains With Latent Membrane Protein-1 Deletions: Prevalence in the Italian Population and High Association With Human Immunodeficiency Virus-Related Hodgkin's Disease Blood, March 1, 1997; 89(5): 1723 - 1731. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.J. Delecluse, I. Anagnostopoulos, F. Dallenbach, M. Hummel, T. Marafioti, U. Schneider, D. Huhn, A. Schmidt-Westhausen, P.A. Reichart, U. Gross, et al. Plasmablastic Lymphomas of the Oral Cavity: A New Entity Associated With the Human Immunodeficiency Virus Infection Blood, February 15, 1997; 89(4): 1413 - 1420. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Lynch and N. L. Harris Case 27-1994- A 41-Year-Old Woman with Neurologic Abnormalities and an Osteolytic Lesion in the Mandible N. Engl. J. Med., July 14, 1994; 331(2): 107 - 113. [Full Text] |
||||
![]() |
U. Tirelli, S. Franceschi, and A. Carbone Malignant tumours in patients with HIV infection BMJ, April 30, 1994; 308(6937): 1148 - 1153. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |